Hereditary Antithrombin Deficiency Story to Appear on The Balancing Act, January 28th
January 25, 2013
rEVO Biologics announced today that hereditary antithrombin (AT) deficiency, and the use of the company’s lead product ATryn antithrombin (Recombinant), will be the focus of a TV segment on Behind the Mystery: Rare and Genetic Diseases, the ground breaking series on The Balancing Act™, America’s premier morning show that airs weekday mornings on Lifetime Television.
The segment will air on Lifetime at 7:00 am (ET/PT) on January 28th, 2013. Along with raising awareness about hereditary AT deficiency, the segment discusses the need for pregnant women to seek simple blood tests to diagnose this genetic disorder. See a preview of the segment.
Dr. Michael Paidas, professor at Yale School of Medicine, and co-director of the Yale Women and Children’s Center for Blood Disorders, will appear on the Behind the Mystery segment to provide important information about hereditary AT deficiency diagnosis and treatment.
The Balancing Act™, America’s premier morning show airs weekday mornings on Lifetime Television at 7:00 am (ET/PT).
Sign up for updates straight to your inbox.